Xspray Pharma: Continues to deliver good news

Research Note

2019-10-31

13:18

Xspray has achieved a vital milestone and received approval from the FDA for its Investigational New Drug (IND) application.

JS

Jakob Svensson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.